@article{c0cf2ce81ff2421ea61eca944fcc7ebb,
title = "Challenges stemming from NIH's extended registration and reporting requirements",
author = "Evan Mayo-Wilson and Kay Dickersin",
note = "Funding Information: Up to 2008, K.D. served as an unpaid expert witness for the plaintiffs{\textquoteright} lawyers (Greene LLP) in litigation against Pfizer related to reporting of gabapentin trials. Thomas Greene has donated funding to Johns Hopkins University for scholarship related to reporting clinical trials. E.M.-W. and K.D. conduct research about reporting clinical trials, and they have received funding for their research from multiple funders including the National Institutes of Health and the US Food and Drug Administration.",
year = "2018",
month = feb,
day = "1",
doi = "10.1038/s41562-017-0286-z",
language = "English (US)",
volume = "2",
pages = "97",
journal = "Nature Human Behaviour",
issn = "2397-3374",
publisher = "Nature Publishing Group",
number = "2",
}